The WHO says multidrug resistance TB or MDR-TB comprises three percent of new TB cases globally. Bangladesh estimates the MDR-TB rate 6 per 100,000 people. But in case of the MDR-TB, which is the outcome of mismanagement of TB treatment, the cure rate is 50 percent. The MDR-TB treatment is also comparatively difficult as patients have to take drugs for two years, compared with six to nine months for general TB. The WHO has recently approved a shorter treatment for MDR-TB to nine months from two years after Bangladesh study showed success.

Source: bd News24 October 25, 2016 14:48 UTC